STOCKSCREENR

ATAI

NASDAQ

Atai Beckley N.V

$4.16+0.04(+0.97%)Mkt Cap: $784.68M

Key Stats

Market Cap

$784.68M

P/E Ratio

-1.43

EPS

$-2.91

Dividend Yield

0.00%

52-Week Range

$1.29 — $6.75

Volume

4.13M

Avg Volume

5.71M

Beta

1.57

Price Alerts for ATAI

Get alerted when ATAI hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-1.43

Forward P/E

—

PEG Ratio

0.01

P/S (TTM)

191.90

P/B (TTM)

5.89

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-3.90%

ROA (TTM)

-2.13%

ROIC

—

Gross Margin

-1.65%

Operating Margin

-28.63%

Net Margin

—

Debt/Equity

0.01

Current Ratio

11.74

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.70%

EPS Growth (5Y)

-1.48%

Sales Growth (3Y)

-0.22%

Sales Growth (5Y)

-0.13%

EPS Est (This Year)

$-0.48

EPS Est (Next Year)

$-0.48

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.81

Analyst Consensus

Price Target Range

$10.00$11.50$14.00
LowMedianHigh

Consensus Target: $11.75(182.5% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

188.63M

Float

102.49M

Free Float %

54.34%

Technicals

RSI (14)

46.64

SMA 20

$3.81

SMA 50

$3.88

SMA 200

$4.06

ATR (14)

0.32

Volatility (Week)

0.06%

Volatility (Month)

0.06%

Pattern

—

Performance

1 Day

+0.00%

1 Week

-14.98%

1 Month

-3.91%

3 Months

-3.91%

6 Months

-19.61%

1 Year

—

YTD

-4.65%

All-Time High

$6.75

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

NL

Exchange

NASDAQ

IPO Date

2021-06-18

Employees

54

CEO

Srinivas G. Rao

Index Membership

—

Website

https://www.ataibeckley.com

Atai Beckley N.V (ATAI) is a healthcare company in the medical - pharmaceuticals industry listed on the NASDAQ. With a market capitalization of $784.68M, a P/E ratio of -1.43, ATAI is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ATAI against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0RU5.L

Oncoinvent ASA

$49.50

+3.13%

$1.94B

0L35.L

Sarepta Therapeutics, Inc.

$21.09

+2.59%

$2.11B

LFMD

LifeMD, Inc.

$4.68

+5.64%

$224.52M

0IMT.L

Photocure ASA

$65.10

-4.41%

$1.73B

0QLN.L

Tecan Group AG

$117.70

+1.90%

$1.48B

0UNL.L

Nektar Therapeutics

$85.11

+2.57%

$1.73B

Frequently Asked Questions

What is Atai Beckley N.V's P/E ratio?

Atai Beckley N.V (ATAI) has a trailing twelve-month (TTM) P/E ratio of -1.43. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Atai Beckley N.V pay a dividend?

No, Atai Beckley N.V (ATAI) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Atai Beckley N.V's market cap?

Atai Beckley N.V (ATAI) has a market capitalization of $784.68 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has ATAI performed this year?

Atai Beckley N.V (ATAI) has returned -4.65% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.